Drawing for USA MEDICAL

USPTO serial 79303507

USA MEDICAL

Reviewed by CopyMark Law Group

Reg. 6571493Status 700Renewal
Filing date
Status date
Registration date
Nov 30, 2021
Examiner
LIU, PHILIP HUAI-EN
Law office
PUBLICATION AND ISSUE SECTION

What this means

This registration is in, or will soon enter, a USPTO maintenance window. Missing a Section 8 or Section 9 filing can cancel the registration.

Status 700: Status 700 means the trademark is registered and active on the Principal Register. You have nationwide rights for the listed goods and services and may use ®. Section 8 maintenance is due between years five and six.

Need help with USA MEDICAL?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Get help with this Renewal, set up monitoring, or talk with CopyMark.
Get Attorney Assistance for just $299*

Plus Government fees of $325

Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Goods and services

ClassDescriptionStatusFirst use
005Dietary supplements for humans and animalsACTIVE—

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

DateCodeEventWhat it means
Jun 12, 2022FINOFINAL DECISION TRANSACTION PROCESSED BY IB—
May 20, 2022FICSFINAL DISPOSITION NOTICE SENT TO IB—
May 20, 2022FIMPFINAL DISPOSITION PROCESSED—
Feb 28, 2022FICRFINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB—
Feb 11, 2022CHLDCHANGE OF OWNER RECEIVED FROM IB—
Nov 30, 2021R.PRREGISTERED-PRINCIPAL REGISTERYour trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive.
Sep 14, 2021NPUBOFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED—
Sep 14, 2021NPUBOFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED—
Sep 14, 2021NPUBOFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED—
Sep 14, 2021PUBOPUBLISHED FOR OPPOSITIONYour mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance.
Aug 26, 2021NONPNOTIFICATION OF NOTICE OF PUBLICATION E-MAILED—
Aug 26, 2021NONPNOTIFICATION OF NOTICE OF PUBLICATION E-MAILED—
Aug 26, 2021NONPNOTIFICATION OF NOTICE OF PUBLICATION E-MAILED—
Aug 9, 2021CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER—
Aug 9, 2021XAECEXAMINER'S AMENDMENT ENTERED—
Aug 9, 2021GNENNOTIFICATION OF EXAMINERS AMENDMENT E-MAILED—
Aug 9, 2021GNEAEXAMINERS AMENDMENT E-MAILED—
Aug 9, 2021CNEAEXAMINERS AMENDMENT -WRITTEN—
Aug 6, 2021TEMETEAS/EMAIL CORRESPONDENCE ENTERED—
Aug 6, 2021CRFACORRESPONDENCE RECEIVED IN LAW OFFICE—
Aug 6, 2021TROATEAS RESPONSE TO OFFICE ACTION RECEIVEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Jun 20, 2021RFNTREFUSAL PROCESSED BY IB—
Jun 1, 2021RFCSNON-FINAL ACTION MAILED - REFUSAL SENT TO IB—
Jun 1, 2021RFRRREFUSAL PROCESSED BY MPU—
May 28, 2021RFCRNON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW—
May 27, 2021CNRTNON-FINAL ACTION WRITTENA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
May 26, 2021DOCKASSIGNED TO EXAMINER—
Feb 13, 2021MAFRAPPLICATION FILING RECEIPT MAILED—
Feb 9, 2021NWOSNEW APPLICATION OFFICE SUPPLIED DATA ENTERED—
Feb 4, 2021REPRSN ASSIGNED FOR SECT 66A APPL FROM IB—

Frequently asked questions

Related guidance